Equity Profile

ELAN

Elanco Animal Health Incorporated

Health CarePharmaceuticals$11.8B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Elanco Animal Health Incorporated focuses on providing pharmaceuticals and health products for pets and livestock. As a key player in the health care sector, it addresses the growing demand for animal health solutions amid increasing pet ownership and livestock management needs.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELAN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+20.15%

Avg Stock Reaction

+9.36%

Last Quarter Recap

In Q1-2026, Elanco reported an EPS of $0.40, exceeding expectations by 16.28%. The stock reacted positively, rising 13.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic ahead of Elanco's earnings report, given the company's strong recent performance. However, the lack of specific guidance leaves some uncertainty.

Bull Case

If Elanco continues its trend of beating EPS estimates, it could see significant stock appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, as seen in previous quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given Elanco's strong track record of beating EPS estimates, the market will closely watch this figure to gauge ongoing profitability.

How is revenue growth trending compared to last quarter?

Revenue growth is critical for assessing the company's market position and future potential, especially in a competitive industry.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Elanco's ability to leverage recent product innovations, which could drive stronger-than-expected revenue growth.

Supporting Evidence

Elanco has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a lower expected move compared to historical averages, indicating potential undervaluation of the stock's volatility.

The company's recent product launches have not been fully accounted for in consensus estimates.

Key Risk

If Elanco's revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Elanco can sustain its recent performance amid competitive pressures and changing market dynamics.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.30 would support the bear case, suggesting potential issues in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±9.24%

Historical Avg

±11.3%

Pricing cheap

The options market is pricing in a potential move of about 9.24%, indicating some uncertainty surrounding the earnings report.

Options are pricing ±9.2% while ELAN has averaged ±11.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

67.6%

Calls (8K)P/C Ratio: 0.17Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elanco beats expectations, history suggests a potential stock increase of around 11.22%, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If the company misses estimates, history indicates a potential decline of about 3.69%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their market reception.
2Insights into cost management and operational efficiencies.
3Comments on competitive pressures and market share trends.
4Guidance on future revenue expectations and growth strategies.
5Management's outlook on the overall animal health market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and will help gauge the company's financial health this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet customer demand.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ELAN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+20.15%

Avg Stock Reaction

+9.36%

Last Quarter Recap

In Q1-2026, Elanco reported an EPS of $0.40, exceeding expectations by 16.28%. The stock reacted positively, rising 13.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic ahead of Elanco's earnings report, given the company's strong recent performance. However, the lack of specific guidance leaves some uncertainty.

Bull Case

If Elanco continues its trend of beating EPS estimates, it could see significant stock appreciation, especially if revenue growth is also strong.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, as seen in previous quarters.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given Elanco's strong track record of beating EPS estimates, the market will closely watch this figure to gauge ongoing profitability.

How is revenue growth trending compared to last quarter?

Revenue growth is critical for assessing the company's market position and future potential, especially in a competitive industry.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Elanco's ability to leverage recent product innovations, which could drive stronger-than-expected revenue growth.

Supporting Evidence

Elanco has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a lower expected move compared to historical averages, indicating potential undervaluation of the stock's volatility.

The company's recent product launches have not been fully accounted for in consensus estimates.

Key Risk

If Elanco's revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Elanco can sustain its recent performance amid competitive pressures and changing market dynamics.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.30 would support the bear case, suggesting potential issues in revenue generation.

Pre-Earnings Positioning

Options Market

Implied Move

±9.24%

Historical Avg

±11.3%

Pricing cheap

The options market is pricing in a potential move of about 9.24%, indicating some uncertainty surrounding the earnings report.

Options are pricing ±9.2% while ELAN has averaged ±11.3% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

67.6%

Calls (8K)P/C Ratio: 0.17Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Elanco beats expectations, history suggests a potential stock increase of around 11.22%, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

If the company misses estimates, history indicates a potential decline of about 3.69%, raising concerns about future performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their market reception.
2Insights into cost management and operational efficiencies.
3Comments on competitive pressures and market share trends.
4Guidance on future revenue expectations and growth strategies.
5Management's outlook on the overall animal health market.